Feasibility Study of Erythrocyte Long-Chain Omega-3 Polyunsaturated Fatty Acid Content and Mortality Risk in Hemodialysis Patients

Journal of Renal Nutrition

Volumn 18, Issue 6, 2008, Pages 509-512

  Friedman, Allon N ^a,b   Saha, Chandan ^a   Watkins, Bruce A ^b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; OMEGA 3 FATTY ACID;

AGE; ARTICLE; BLOOD; CHEMISTRY; CHRONIC KIDNEY FAILURE; COMORBIDITY; ERYTHROCYTE; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK FACTOR; SAMPLE SIZE; SURVIVAL RATE;

AGE FACTORS; BIOLOGICAL MARKERS; COMORBIDITY; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FEASIBILITY STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SAMPLE SIZE; SURVIVAL RATE;

EID: 53749097328     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2008.08.007     Document Type: Article

References (20)

1. Kris-Etherton P.M., Harris W.S., and Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106 (2002) 2747-2757
2. Saifullah A., Watkins B., Saha C., Li Y., Moe S., and Friedman A. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients-a pilot study. Nephrol Dial Transplant 22 (2007) 3561-3567
3. Friedman A.N., Moe S.M., Perkins S.M., Li Y., and Watkins B.A. Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis. Am J Kidney Dis 47 (2006) 1064-1071
4. Kutner N.G., Clow P.W., Zhang R., and Aviles X. Association of fish intake and survival in a cohort of incident dialysis patients. Am J Kidney Dis 39 (2002) 1018-1024
5. Friedman A., Siddiqui R., and Watkins B. Acute rise of omega-3 polyunsaturated fatty acids during hemodialysis treatment. J Ren Nutr 18 (2008) 301-303
6. Watkins B.A., Li Y., Allen K.G., Hoffmann W.E., and Seifert M.F. Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats. J Nutr 130 (2000) 2274-2284
7. Harris W., and Schacky C.V. The omega-3 index: a new risk factor for death from coronary heart disease?. Prev Med 39 (2004) 212-220
8. Charlson M.E., Pompei P., and Ales K.L. MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
9. Dwyer J.H., Allayee H., Dwyer K.M., et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 350 (2004) 29-37
10. Leaf A., Kang J.X., Xiao Y.F., and Billman G.E. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 107 (2003) 2646-2652
11. Appel L.J., Miller III E.R., Seidler A.J., and Whelton P.K. Does supplementation of diet with "fish oil" reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 153 (1993) 1429-1438
12. Phillipson B.E., Rothrock D.W., Connor W.E., Harris W.S., and Illingworth D.R. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 312 (1985) 1210-1216
13. Siscovick D.S., Raghunathan T.E., King I., et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274 (1995) 1363-1367
14. Albert C.M., Campos H., Stampfer M.J., et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346 (2002) 1113-1118
15. Wang C., Harris W.S., Chung M., et al. n-3 fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 84 (2006) 5-17
16. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354 (1999) 447-355
17. Mozaffarian D., and Rimm E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296 (2006) 1885-1899
18. Yokoyama M., Origasa H., Matsuzaki M., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369 (2007) 1090-1098
19. Gebauer S.K., Psota T.L., and Harris W.S. Kris-Etherton PM: n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 83 Suppl. (2006) 1526S-1535S
20. Svensson M., Schmidt E., Jorgensen K., and Christensen J. N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial. Clin J Am Soc Nephrol 1 (2006) 780-786